The use of EEG in Alzheimer's disease, with and without scopolamine - A pilot study

J. Snaedal, G. H. Johannesson, Th E. Gudmundsson, S. Gudmundsson, T. H. Pajdak, K. Johnsen*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)


Objective: To use multivariate statistical analysis of EEG data in order to separate EEGs of patients with Alzheimer's disease (AD) from controls. A group of individuals with mild cognitive impairment (MCI) was evaluated using the same methodology. Additionally, the effects of scopolamine on this separation are studied. Methods: Statistical pattern recognition (SPR) is used in conjunction with information extracted from EEGs before and after administration of scopolamine. Results: There was complete separation of the AD group and controls before administration of scopolamine. The separation increased after scopolamine had been given. Of the 10 MCI individuals, five seemed to belong to the AD group. Three of those progressed to AD within 1 year and one after 3 years. Conclusions: Using SPR on EEG recordings it is possible to separate AD from controls. This separation can be increased by the use of scopolamine but the medication is not a prerequisite for classification. The results indicate that SPR is useful for predicting progress of MCI to AD. Significance: EEG registration is a simple and noninvasive method. If these results are confirmed in other studies, this method could be more widely applied than the highly specialized methods used today in detection of early AD.

Original languageEnglish
Pages (from-to)836-841
Number of pages6
JournalClinical Neurophysiology
Issue number6
Publication statusPublished - Jun 2010

Other keywords

  • Alzheimer's disease
  • Electroencephalography
  • Mild cognitive impairment
  • Scopolamine


Dive into the research topics of 'The use of EEG in Alzheimer's disease, with and without scopolamine - A pilot study'. Together they form a unique fingerprint.

Cite this